Bath & Body Works logged a 2.3% change during today's afternoon session, and is now trading at a price of $41.22 per share. The S&P 500 index moved 1.5% and the Nasdaq posted a 1.5% change. BBWI's trading volume is 1,284,136 compared to the stock's average volume of 3,957,098.
Over the last 52 weeks, the stock moved -41.2%, with a high of $71.51 and a low of $25.75. During this time, the stock lagged the S&P 500 index by -22.6%. Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The mid-cap Consumer Cyclical company has 8,800 full time employees and is based in Columbus, OH. Bath & Body Works has returned a 1.9% dividend yield over the last 12 months.
Snapshot of the Company's Strong Margins and Cash Flows:
| 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | |
|---|---|---|---|---|
| Revenue (MM) | $13,237 | $12,914 | $11,847 | $7,882 |
| Revenue Growth | n/a | -2.4% | -8.3% | -33.5% |
| Gross Margins | 37.01% | 34.46% | 39.39% | 48.91% |
| Gross Margins Growth | n/a | -6.89% | 14.31% | 24.17% |
| Earnings Per Share | $2.31 | $-1.32 | $3.0 | $4.88 |
| EPS Growth | n/a | -157.14% | 327.27% | 62.67% |
| Free Cash Flow (MM) | $748 | $778 | $1,811 | $1,222 |
| FCF Growth | n/a | 4.01% | 132.78% | -32.52% |
| Net Debt / EBITDA | 2.28 | 3.01 | 1.49 | 1.4 |
Most Valuation Metrics Show Bath & body works Is Undervalued:
Compared to the Consumer Cyclical sector's average of 24.11, Bath & Body Works has a trailing twelve month price to earnings (P/E) ratio of 11.0 and, based on its Eps guidance of 3.7, an expected P/E ratio of 11.1. However, the firm's price to earnings growth (PEG) is 4.41, which indicates that it is overvalued in terms of its expected rate of earnings growth. .
There is Positive Market Sentiment About Bath & Body Works:
19 analysts are following Bath & Body Works and have set target prices ranging from $39 to $76 per share. On average, they have given the company a rating of buy. At today's prices, BBWI is trading -17.21% away from its average analyst target price of $49.79 per share, implying an analyst consensus of some upside potential for the stock.
The company has an average amount of shares sold short since 7.6% of the company's shares are tied to short positions. Institutions own 99.0% of Bath & Body Works's shares, while the insider ownership rate stands at 2.67%. The biggest shareholder is the Vanguard Group, Inc. with a 11.04% stake in the company worth approximately $1,039,899,345.00.
